Dr. O’Reardon was involved in the development of TMS as a treatment for major depressive disorder from the very beginning. For example, see the large, international randomized, sham-controlled clinical trial for which he was the first author (O’Reardon et al., 2007).
He is a leading expert in this treatment; e.g., he was one of the experts who wrote guidelines for the use of TMS published in 2018 (McClintock et al., 2018).
For SPMH’s video interview with Dr. O’Reardon, click HERE.
For his private practice website, click HERE.
Dr. O’Reardon completed his residency training in psychiatry at the University of Pennsylvania, and subsequently fellowships in psychopharmacology and in cognitive therapy. He was a Van Ameringen fellow at the Beck Institute for Cognitive Therapy and is a founding fellow of the Academy of Cognitive Therapy. Dr. O’Reardon is a Diplomate of the American Board of Psychiatry and Neurology.
Dr. O’Reardon’s clinical and research interests include treatment-resistant mood disorders, the development of novel neuromodulation therapies in psychiatry such as TMS, VNS, tDCS, and deep brain stimulation (DBS) along with cognitive therapy, and the night eating syndrome. He has served as an investigator in numerous clinical trials of therapeutic interventions including medications, cognitive therapy, TMS, VNS, DBS, and tDCS. He was a full-time faculty member at the University of Pennsylvania for 15 years and attained Associate Professor rank there. He is currently in private practice.
He has made many contributions to the literature in his areas of interest in leading specialty journals including the Archives of General Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, and the American Journal of Psychiatry. He has more than 100 peer-reviewed scientific publications. He has been teaching faculty at the American Psychiatric Association, Institute of Psychiatric Services and International Society for ECT and Neurostimulation (ISEN), Clinical Transcranial Magnetic Stimulation Society (CTMSS) annual meetings in the area of mood disorders and neuromodulation treatments.
Related Pages
How to refer your patient for TMS
Primer on TMS: An expert interview with Dr. John O’Reardon
Copyright © 2018 to 2020, Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply